DXCM DexCom, Inc. Stock Quote

DXCM [NASD]

Healthcare | Diagnostics & Research | USA

Index	S&P 500	P/E	111.29	EPS (ttm)	5.32	Insider Own	0.40%	Shs Outstand	96.90M	Perf Week	-8.71%
Market Cap	58.02B	Forward P/E	162.85	EPS next Y	3.63	Insider Trans	-27.06%	Shs Float	96.49M	Perf Month	5.98%
Income	529.30M	PEG	6.79	EPS next Q	1.15	Inst Own	98.30%	Short Float	3.77%	Perf Quarter	13.68%
Sales	2.32B	P/S	25.02	EPS this Y	362.20%	Inst Trans	-1.72%	Short Ratio	6.77	Perf Half Y	60.25%
Book/sh	22.04	P/B	26.86	EPS next Y	29.82%	ROA	11.80%	Target Price	638.88	Perf Year	89.40%
Cash/sh	27.53	P/C	21.50	EPS next 5Y	16.40%	ROE	26.90%	52W Range	311.01 - 659.45	Perf YTD	60.11%
Dividend	-	P/FCF	415.90	EPS past 5Y	55.20%	ROI	15.80%	52W High	-10.23%	Beta	0.77
Dividend %	-	Quick Ratio	4.50	Sales past 5Y	36.80%	Gross Margin	69.80%	52W Low	90.33%	ATR	20.17
Employees	5500	Current Ratio	5.00	Sales Q/Q	29.80%	Oper. Margin	15.90%	RSI (14)	43.75	Volatility	4.02% 3.69%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-2.80%	Profit Margin	22.80%	Rel Volume	0.67	Prev Close	598.58
Shortable	Yes	LT Debt/Eq	0.82	Earnings	Oct 28 AMC	Payout	0.00%	Avg Volume	538.23K	Price	591.96
Recom	1.60	SMA20	-5.75%	SMA50	1.71%	SMA200	28.39%	Volume	361,861	Change	-1.11%

Oct-18-21

Downgrade

Guggenheim

Buy → Neutral

Jul-21-21

Resumed

Cowen

Outperform

$540 → $525

May-28-21

Upgrade

Wells Fargo

Underweight → Equal Weight

$380

May-25-21

Initiated

Barclays

Overweight

$500

Apr-15-21

Initiated

Atlantic Equities

Overweight

$438

Jan-06-21

Upgrade

UBS

Neutral → Buy

$410 → $445

Oct-02-20

Downgrade

Wells Fargo

Equal Weight → Underweight

$420 → $350

May-27-20

Reiterated

Piper Sandler

Overweight

$375 → $450

May-14-20

Initiated

Wells Fargo

Equal Weight

$420

Mar-05-20

Initiated

Citigroup

Buy

$330

Nov-07-19

Upgrade

Guggenheim

Neutral → Buy

Nov-07-19

Reiterated

Canaccord Genuity

Buy

$185 → $195

Oct-23-19

Initiated

Stifel

Buy

Nov-28-18

Initiated

UBS

Neutral

$135

Oct-19-18

Upgrade

Goldman

Sell → Neutral

Sep-12-18

Upgrade

Northland Capital

Under Perform → Market Perform

Aug-02-18

Reiterated

Canaccord Genuity

Buy

$105 → $125

Jul-02-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-08-18

Upgrade

JP Morgan

Neutral → Overweight

May-11-18

Initiated

BofA/Merrill

Buy

$100

Nov-26-21 04:24PM	What Clue Led To Final Sell On Dexcom Stock? Investor's Business Daily
Nov-18-21 11:45AM	3 Reasons This Stock Could 10X in 10 Years Motley Fool
Nov-17-21 06:12AM	3 Stocks to Add to Your Portfolio in the Event of a Market Downturn Motley Fool
05:58AM	Better Buy: DexCom or Abbott Labs? Motley Fool
Nov-15-21 11:21AM	Jim Cramer Stock Portfolio: 10 Recent Additions Insider Monkey
Nov-08-21 10:02AM	Was The Smart Money Right About DexCom, Inc. (DXCM)? Insider Monkey
Nov-04-21 10:06AM	Reviewing DexCom for a New Strategy TheStreet.com
09:00AM	Is DexCom, Inc.'s (NASDAQ:DXCM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? Simply Wall St.
Nov-02-21 12:20PM	Earnings Estimates Rising for DexCom (DXCM): Will It Gain? Zacks
Nov-01-21 09:37AM	Company News for Nov 1, 2021 Zacks
08:45AM	Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November Business Wire
Oct-29-21 04:12PM	Dexcom Breaks Out To Record High; How It's Taking On Giants In Diabetes Investor's Business Daily +9.27%
01:11PM	Dexcom Breaks Out To Record High; How It's Taking On Giants In Diabetes Investor's Business Daily
12:02PM	Dexcom Q3 Earnings Beat Street, Raises FY21 Outlook Ahead Of G7 Launch Benzinga
10:36AM	DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates Zacks
08:18AM	Dow Jones Futures Dip, Nasdaq Futures Fall Sharply On Apple, Amazon; What To Do Now Investor's Business Daily
Oct-28-21 09:01PM	DexCom Inc (DXCM) Q3 2021 Earnings Call Transcript Motley Fool
05:35PM	DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates Zacks
04:02PM	Dexcom Reports Third Quarter 2021 Financial Results Business Wire
Oct-27-21 08:37AM	Is a Surprise Coming for DexCom (DXCM) This Earnings Season? Zacks
06:51AM	The Zacks Analyst Blog Highlights: Capital One Financial, Thermo Fisher Scientific, Aflac, DexCom and Exxon Mobil Zacks
Oct-26-21 06:14AM	5 S&P 500 Stocks to Buy Ahead of Q3 Earnings This Week Zacks
Oct-21-21 03:02PM	DexCom (DXCM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
10:18AM	DexCom (DXCM) to Report Q3 Earnings: What's in the Cards? Zacks
07:35AM	2 Unstoppable Stocks to Buy and Hold for Decades Motley Fool
Oct-20-21 12:10PM	Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report? Zacks
Oct-18-21 08:57AM	The Zacks Analyst Blog Highlights: Edwards Lifesciences, DexCom, Twitter, Cigna Corp and Restaurant Brands Zacks
Oct-15-21 02:49PM	Top Analyst Reports for Edwards Lifesciences, DexCom & Twitter Zacks
Oct-13-21 04:00AM	Dexcom Expands Time in Range Initiative with Nick Jonas to Help Improve the Lives of People with Diabetes in the UK Business Wire
Oct-12-21 11:30AM	Got $1,000? These 2 High-Growth Stocks Are Screaming Buys Right Now Motley Fool
Oct-07-21 11:41AM	Here's Why You Should Add DexCom (DXCM) Stock to Your Portfolio Zacks
Oct-06-21 11:28AM	Notable Dexcom Insider Makes $270K Sale Benzinga
08:19AM	Dow Jones Futures Tumble: Look For This Market Rally Signal; Google, Datadog Lead 9 Stocks To Watch Investor's Business Daily
Oct-05-21 01:30PM	Dexcom Looks Healthy Investor's Business Daily Video
08:45AM	Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time Business Wire
07:21AM	3 Innovative Growth Stocks That'll Make You Richer Through 2025 Motley Fool
Oct-04-21 12:04PM	Do Hedge Funds Love DexCom, Inc. (DXCM)? Insider Monkey
11:40AM	Dexcom's (DXCM) G6 CGM System Gets Coverage in Manitoba Zacks
Sep-30-21 10:30AM	The best and worst stock performers in Q3 Yahoo Finance Video
Sep-29-21 09:15AM	1 Supercharged Healthcare Stock to Buy Right Now Motley Fool
07:35AM	Is Now The Time To Put DexCom (NASDAQ:DXCM) On Your Watchlist? Simply Wall St.
06:00AM	Dexcom G6 Continuous Glucose Monitoring System Now Covered in Manitoba for Young People With Type 1 Diabetes Business Wire
Sep-28-21 11:00AM	Ignore GameStop: Here Are 2 Better Stocks Motley Fool
Sep-15-21 10:30AM	2 Sizzling Hot Stocks to Buy Right Now Motley Fool
Sep-14-21 11:05AM	Dexcom's (DXCM) G6 CGM Under NIHB Program to Aid More Patients Zacks
Sep-13-21 01:00PM	Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy Business Wire
12:58PM	Here's Why iRhythm Technologies Stock Is Making Big Gains Today Motley Fool
08:30AM	If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now Zacks
Sep-05-21 05:39AM	3 Growth Stocks That'll Make You Richer By 2024 Motley Fool
Sep-02-21 08:45AM	Dexcom Announces Upcoming Virtual Conference Presentations Business Wire
Aug-28-21 08:00AM	Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points Investor's Business Daily
Aug-27-21 08:30AM	If You Invested $1000 in DexCom 10 Years Ago, This Is How Much You'd Have Now Zacks
Aug-24-21 07:25AM	Those who invested in DexCom (NASDAQ:DXCM) five years ago are up 459% Simply Wall St.
Aug-10-21 08:30AM	If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now Zacks
05:43AM	3 Growth Stocks to Buy and Hold Regardless of What Happens With the Delta Variant Motley Fool
Aug-03-21 09:49AM	2 Top Growth Stocks That Could Help Your Portfolio Shine Motley Fool
Jul-31-21 10:41PM	3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain Motley Fool
Jul-30-21 05:45PM	These 2 Winning Stocks Came Out of Nowhere Friday Motley Fool +13.04%
01:23PM	Dexcom Stock Jumps As Q2 Earnings Beats Street, Raises Guidance; Analysts Bump Up Target Price Benzinga
11:39AM	Why Shares of Dexcom Are Gaining This Morning Motley Fool
09:13AM	DexCom (DXCM) Q2 Earnings and Revenues Surpass Estimates Zacks
05:08AM	The Technical Risks and Rewards of Trading DexCom Stock TheStreet.com
Jul-29-21 11:32PM	DexCom Inc (DXCM) Q2 2021 Earnings Call Transcript Motley Fool
05:35PM	DexCom (DXCM) Beats Q2 Earnings and Revenue Estimates Zacks
04:02PM	Dexcom Reports Second Quarter 2021 Financial Results Business Wire
Jul-23-21 07:54AM	DexCom (DXCM) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-22-21 03:03PM	Analysts Estimate DexCom (DXCM) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-19-21 10:32AM	Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod Zacks
02:32AM	DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly Simply Wall St.
Jul-15-21 04:51PM	FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices Business Wire
Jul-07-21 08:45AM	Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time Business Wire
Jul-06-21 08:46AM	New Strong Sell Stocks for July 6th Zacks
Jul-01-21 04:58PM	Why IBD Stock Of The Day Dexcom Has Sprinted Off The Bottom Of A Cup Base Investor's Business Daily
Jun-25-21 08:45AM	Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes Association Business Wire
07:41AM	Diabetes Space Thrives on CGM Devices in 2021: 3 Stocks in Focus Zacks
Jun-24-21 10:09AM	10 Best Stocks to Buy According to Chris James Engine No. 1 Insider Monkey
10:00AM	DexCom, Nick Jonas and Leading Diabetes Nonprofits Launch Initiative to Help Improve the Lives of People With Diabetes Business Wire
Jun-22-21 09:14AM	Endurance Athlete Sébastien Sasseville to Ride Across Canada in Support of JDRFs Access For All Campaign Business Wire
Jun-18-21 06:00AM	Senseonics Has Too Much Hope for Success Priced in Already InvestorPlace
Jun-16-21 04:00PM	DexCom, Inc. (DXCM): Are Hedge Funds Right About This Stock? Insider Monkey
Jun-15-21 11:27AM	Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia Zacks
Jun-14-21 06:00AM	Apple Plans Faster Watch, Future Temperature and Glucose Sensors Bloomberg
Jun-13-21 04:11AM	DexCom (NASDAQ:DXCM) Might Have The Makings Of A Multi-Bagger Simply Wall St.
Jun-11-21 01:28PM	British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy Business Wire
Jun-10-21 10:22AM	Making Money in the Stock Market Is Easy -- If You Avoid This 1 Thing Motley Fool
Jun-03-21 11:11AM	Dexcom Looks to the Future of Continuous Glucose Monitoring Business Wire
Jun-01-21 08:00AM	12 Stocks Boom Every June Investor's Business Daily
06:00AM	Saskatchewan Health to Cover Dexcom G6 Continuous Glucose Monitoring System for People with Diabetes under the age of 18 CNW Group
May-27-21 08:45AM	Dexcom Announces Upcoming Conference Presentation Business Wire
06:18AM	Investing $5,000 in These 2 Stocks Could Make You a Fortune Motley Fool
May-26-21 06:00AM	RAMQ Now Offers Provincial Coverage of The Dexcom G6 Continuous Glucose Monitoring System for People Living with Type 1 Diabetes in Quebec CNW Group
May-24-21 03:17PM	Why DexCom Stock Jumped Today Motley Fool
May-20-21 06:24AM	3 Top Healthcare Stocks to Buy Right Now Motley Fool
May-14-21 01:19PM	If You Do the Math, Senseonics Makes No Sense InvestorPlace
02:56AM	DexCom, Inc. (NASDAQ:DXCM) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? Simply Wall St.
May-13-21 04:21PM	These 7 Medical Stocks Are Breaking Down The Sell Rule You Should Know Investor's Business Daily
10:21AM	2 Top Growth Stocks on Sale After Earnings Motley Fool
May-10-21 05:21PM	10 Beaten-Down Stocks That Could See a Rebound Barrons.com
May-04-21 06:34PM	Was The Smart Money Right About DexCom (DXCM)? Insider Monkey
Apr-30-21 12:06PM	Why DexCom Stock Is Dropping Today Motley Fool -8.44%

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stern Sadie	EVP Chief Human Resources Off	Nov 23	Sale	612.26	1,195	731,651	11,790	Nov 23 06:57 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Nov 23	Sale	612.26	250	153,065	40,579	Nov 23 06:51 PM
Regan Barry J.	EVP Operations	Nov 22	Sale	638.65	837	534,550	12,671	Nov 23 06:57 PM
Stern Sadie	EVP Chief Human Resources Off	Nov 22	Sale	638.65	856	546,684	12,985	Nov 23 06:57 PM
SAYER KEVIN R	Chairman, CEO & President	Nov 15	Sale	647.84	3,000	1,943,515	84,705	Nov 16 01:11 PM
FOLETTA MARK G	Director	Nov 01	Sale	626.32	500	313,162	13,097	Nov 02 05:13 PM
AUGUSTINOS NICHOLAS	Director	Oct 29	Sale	600.03	2,500	1,500,087	918	Nov 02 05:12 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Oct 22	Sale	570.00	250	142,500	40,829	Oct 25 07:35 PM
SAYER KEVIN R	Chairman, CEO & President	Oct 15	Sale	549.22	6,000	3,295,334	90,705	Oct 18 07:35 PM
Patterson Chad	EVP, Global Marketing	Oct 13	Sale	545.54	141	76,921	9,603	Oct 15 07:13 PM
FOLETTA MARK G	Director	Oct 01	Sale	543.09	500	271,547	13,597	Oct 05 06:28 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Sep 23	Sale	573.34	6,743	3,866,020	41,079	Sep 24 08:01 PM
SAYER KEVIN R	Chairman, CEO & President	Sep 15	Sale	540.58	6,000	3,243,462	96,705	Sep 16 07:01 PM
Patterson Chad	EVP, Global Marketing	Sep 13	Sale	541.47	156	84,469	9,744	Sep 15 04:14 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 10	Sale	558.33	681	380,223	13,014	Sep 13 08:19 PM
Flynn Paul R	EVP, Global Revenue	Sep 10	Sale	558.33	626	349,515	10,928	Sep 13 08:00 PM
Blackford Quentin S.	Chief Operating Officer	Sep 10	Sale	558.33	1,519	848,103	19,280	Sep 10 04:15 PM
Balo Andrew K	*	Sep 09	Sale	546.78	5,597	3,060,337	7,553	Sep 13 08:19 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Sep 09	Sale	546.14	2,223	1,214,059	13,695	Sep 13 08:19 PM
SAYER KEVIN R	Chairman, CEO & President	Sep 09	Sale	541.36	3,017	1,633,280	102,705	Sep 13 08:01 PM
Shrishrimal Sumi	SVP Chief Risk Officer	Sep 09	Sale	541.37	407	220,339	12,234	Sep 13 08:01 PM
Sylvain Jereme M	EVP, Chief Financial Officer	Sep 09	Sale	541.36	407	220,336	13,526	Sep 13 08:01 PM
Flynn Paul R	EVP, Global Revenue	Sep 09	Sale	541.36	752	407,106	11,554	Sep 13 08:00 PM
Leach Jacob Steven	EVP Chief Technology Officer	Sep 09	Sale	541.37	1,263	683,748	69,322	Sep 13 08:00 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Sep 09	Sale	541.36	987	534,327	16,254	Sep 13 08:00 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Sep 09	Sale	541.37	1,263	683,747	47,822	Sep 13 08:00 PM
Patterson Chad	EVP, Global Marketing	Sep 09	Sale	541.37	291	157,538	9,900	Sep 13 08:00 PM
Abbey Donald	EVP Quality and Regulatory Aff	Sep 09	Sale	541.37	1,263	683,747	48,674	Sep 13 07:59 PM
Blackford Quentin S.	Chief Operating Officer	Sep 09	Sale	547.32	9,462	5,178,699	20,799	Sep 10 04:15 PM
Blackford Quentin S.	Chief Operating Officer	Sep 08	Sale	545.87	7,681	4,192,846	30,261	Sep 10 04:15 PM
Sylvain Jereme M	EVP, Chief Financial Officer	Sep 07	Sale	545.41	587	320,156	13,933	Sep 08 06:54 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Aug 26	Sale	517.24	500	258,620	17,241	Aug 27 06:38 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Aug 23	Sale	516.40	1,078	556,678	49,085	Aug 25 04:59 PM
Balo Andrew K	*	Aug 03	Sale	515.87	2,757	1,422,247	10,652	Aug 04 08:36 PM
Leach Jacob Steven	EVP Chief Technology Officer	Jul 30	Sale	476.70	12,087	5,761,873	70,554	Aug 02 06:19 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jul 26	Sale	458.79	500	229,395	17,741	Jul 27 06:04 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Jul 23	Sale	452.18	1,079	487,897	50,163	Jul 27 06:03 PM
Shrishrimal Sumi	SVP Chief Risk Officer	Jul 16	Sale	450.00	400	180,000	12,586	Jul 16 08:40 PM
Balo Andrew K	*	Jul 06	Sale	430.14	2,974	1,279,228	13,409	Jul 08 07:45 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jun 28	Sale	431.49	500	215,745	18,241	Jun 29 07:05 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Jun 23	Sale	426.92	1,079	460,651	51,242	Jun 24 05:59 PM
SKYLER JAY S	Director	Jun 22	Sale	426.37	20,000	8,527,406	13,968	Jun 24 05:59 PM
Shrishrimal Sumi	SVP Chief Risk Officer	Jun 11	Sale	401.09	400	160,436	12,986	Jun 15 06:14 PM
Leach Jacob Steven	EVP Chief Technology Officer	Jun 09	Sale	395.00	22,755	8,988,225	82,641	Jun 10 05:43 PM
AUGUSTINOS NICHOLAS	Director	Jun 03	Sale	366.99	806	295,794	3,110	Jun 07 07:35 PM
Balo Andrew K	*	Jun 03	Sale	375.00	2,391	896,625	16,383	Jun 07 07:33 PM
Blackford Quentin S.	Chief Operating Officer	May 28	Sale	375.00	7,223	2,708,625	37,942	Jun 01 09:14 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	May 26	Sale	350.00	500	175,000	18,741	May 27 05:27 PM
Shrishrimal Sumi	SVP Chief Risk Officer	May 25	Sale	354.79	1,461	518,348	13,386	May 27 05:28 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	May 24	Sale	348.71	1,079	376,260	52,321	May 26 04:57 PM
Sylvain Jereme M	EVP, Chief Financial Officer	May 24	Sale	346.74	600	208,044	14,508	May 26 04:58 PM
SAYER KEVIN R	Chairman, CEO & President	May 03	Sale	379.88	5,535	2,102,626	105,722	May 05 05:35 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Apr 26	Sale	415.83	500	207,915	19,241	Apr 27 06:27 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Apr 23	Sale	410.31	1,079	442,727	53,400	Apr 26 08:09 PM
Flynn Paul R	EVP, Global Revenue	Apr 15	Sale	400.00	758	303,200	12,306	Apr 16 04:44 PM
SAYER KEVIN R	Chairman, CEO & President	Apr 05	Sale	366.67	6,221	2,281,082	111,257	Apr 07 05:05 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Mar 26	Sale	350.00	500	175,000	19,741	Mar 30 05:45 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 23	Sale	360.49	1,109	399,788	6,654	Mar 24 08:18 PM
Pacelli Steven Robert	Managing Dir., Dexcom Ventures	Mar 23	Sale	360.49	1,079	388,967	54,479	Mar 24 08:18 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 11	Sale	355.86	1,867	664,391	16,136	Mar 12 05:41 PM
Sylvain Jereme M	SVP, Finance & CAO	Mar 10	Sale	362.92	941	341,505	15,108	Mar 12 05:42 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 10	Sale	362.92	2,700	979,876	18,003	Mar 12 05:41 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 10	Sale	362.92	5,566	2,019,996	55,558	Mar 12 05:40 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 10	Sale	362.92	14,044	5,096,806	117,478	Mar 12 05:40 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 10	Sale	362.92	5,353	1,942,695	105,396	Mar 12 05:38 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Mar 10	Sale	362.92	3,471	1,259,685	20,241	Mar 12 05:39 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 10	Sale	362.22	6,509	2,357,688	45,165	Mar 12 05:38 PM
Abbey Donald	EVP Quality and Regulatory Aff	Mar 10	Sale	362.92	5,566	2,019,996	49,937	Mar 12 05:36 PM
Balo Andrew K	*	Mar 10	Sale	362.92	5,566	2,019,996	35,307	Mar 12 05:37 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 09	Sale	361.11	3,857	1,392,796	131,522	Mar 10 07:29 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 09	Sale	356.94	152	54,255	20,703	Mar 10 07:29 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Feb 26	Sale	396.79	500	198,395	18,078	Mar 02 07:31 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Feb 24	Sale	404.00	1,110	448,440	7,763	Feb 26 06:01 PM
Sylvain Jereme M	SVP, Finance & CAO	Feb 24	Sale	404.00	600	242,400	10,700	Feb 26 06:02 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 23	Sale	406.98	1,079	439,131	55,823	Feb 24 07:57 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 19	Sale	420.01	1,800	756,025	56,902	Feb 23 06:33 PM
AUGUSTINOS NICHOLAS	Director	Feb 16	Sale	412.03	1,875	772,556	10,092	Feb 17 09:36 PM
SAYER KEVIN R	Chairman, CEO & President	Feb 01	Sale	378.17	12,468	4,714,965	131,934	Feb 03 07:34 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jan 27	Sale	359.70	500	179,850	18,578	Jan 29 05:08 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 22	Sale	368.84	1,110	409,407	8,873	Jan 25 08:21 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jan 22	Sale	368.82	1,079	397,960	58,702	Jan 25 08:21 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 13	Sale	353.55	7,073	2,500,653	144,402	Jan 14 05:06 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 12	Sale	362.09	39,949	14,465,252	151,475	Jan 14 05:06 PM
AUGUSTINOS NICHOLAS	Director	Jan 06	Sale	375.00	625	234,375	11,967	Jan 07 04:40 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 04	Sale	366.06	11,025	4,035,812	21,524	Jan 06 05:10 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Dec 28	Sale	355.39	500	177,695	19,078	Dec 29 08:58 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Dec 23	Sale	359.92	1,110	399,516	9,983	Dec 28 05:43 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Dec 23	Sale	359.85	1,079	388,276	59,781	Dec 28 05:43 PM
AUGUSTINOS NICHOLAS	Director	Dec 16	Sale	354.55	1,250	443,182	12,592	Dec 18 07:53 PM
Heller Bridgette P	Director	Dec 15	Sale	356.65	375	133,744	3,448	Dec 17 05:12 PM
SAYER KEVIN R	Chairman, CEO & President	Dec 01	Sale	322.18	13,233	4,263,358	115,514	Dec 03 05:11 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Dec 01	Sale	325.00	6,154	2,000,050	19,578	Dec 03 05:11 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience